Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Regimen of Bevacizumab Augmentation in Glaucoma Surgeries
TCTR20260721004Phase 4Not yet recruiting
- Sponsor
- Mettapracharak (Wat Rai Khing) Hospital
- Start
- Jan 2027
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of bevacizumab in Glaucoma, sponsored by Mettapracharak (Wat Rai Khing) Hospital. Planned start Jan 2027; status: not yet recruiting.
02
Drugs
bevacizumab
03
Conditions
Glaucoma
Beyond the preview
Go deeper on TCTR20260721004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20260721004.